Quality Improvement in Resident Education: A Pilot Project to Mitigate Metabolic Side Effects from Atypical Antipsychotic Medications in Youth | June 2015

Articles

BMJ Quality Improvement Reports

https://bmjopenquality.bmj.com/content/4/1/u208804.w3544.full

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia: Who Benefits from Blonanserin Augmentation? An Open-Label, Prospective, Multicenter Study | July 2016

Articles

Psychiatry Investigation

https://doi.org/10.4306/pi.2016.13.4.458

Atypical Antipsychotics and Neuroleptic Malignant Syndrome: Nuances and Pragmatics of the Association | February 2017

Articles

BJPsych Bulletin

https://doi.org/10.1192/pb.bp.116.053736

Second-Generation Antipsychotic and Diabetes Mellitus in Children and Adolescents | December 2017

Articles

La Pediatria Medica e Chirurgica

https://dx.doi.org/10.4081/pmc.2017.149

Time to Discontinuation of First- and Second-Generation Antipsychotic Medications in the Treatment of Schizophrenia | May 2011

Articles (Manuscripts-Versions)

PubMed Central>Schizophrenia Research

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935444/

Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder | February 2020

Articles

ClinicoEconomics and Outcomes Research

https://www.dovepress.com/impact-of-atypical-antipsychotics-as-adjunctive-therapy-on-psychiatric-peer-reviewed-article-CEOR

Patterns of Initiation of Second Generation Antipsychotics for Bipolar Disorder: A Month-by-Month Analysis of Provider Behavior | November 2014

Articles

BMC Psychiatry

https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-014-0339-z

Long-Term Effectiveness of Oral Second-Generation Antipsychotics in Patients with Schizophrenia and Related Disorders: A Systematic Review and Meta-Analysis of Direct Head-to-Head Comparisons | May 2019

Articles

World Psychiatry

https://onlinelibrary.wiley.com/doi/full/10.1002/wps.20632

Dietary Energy Intakes in Children with Mental Health Conditions Treated with Second-Generation Antipsychotics | December 2014

Theses-Dissertations

University of British Columbia

http://hdl.handle.net/2429/51651

Are There Any Differences in the Efficacy among Second Generation Antipsychotics in the Treatment of Schizophrenia and Related Disorders? | April 2007

Articles

CLOCKSS Stanford University-Annals of Clinical Psychiatry

http://www.crossref.org/iPage?doi=10.1080/10401230701334606

Effectiveness and Costs of Flupentixol Compared to Other First- and Second-Generation Antipsychotics in the Treatment of Schizophrenia | March 2011

Abstracts

Psychopharmacology

https://link.springer.com/article/10.1007/s00213-011-2256-x

Exploring Biologic Predictors Response Disparities to Atypical Antipsychotics among Blacks: A Quasi-Systematic Review | April 2020

Articles

NCBI>Ethnicity and Disease

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138445/

Medication Adherence, Health Care Utilization, and Costs in Patients with Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment | January 2019

Articles

Clinical Therapeutics

https://www.sciencedirect.com/science/article/pii/S0149291818306040

Use of Second Generation Antipsychotics for Treatment-Resistant Major Depressive Disorder | September 2014

Articles

Mental Health Clinician

https://doi.org/10.9740/mhc.n207192

Effect of Atypical Antipsychotics on Fetal Growth: Is the Placenta Involved? | June 2012

Articles

Journal of Pregnancy

https://www.hindawi.com/journals/jp/2012/315203/

Time to Discontinuation of Second-Generation Antipsychotics versus Haloperidol and Sulpiride in People with Schizophrenia: A Naturalistic, Comparative Study | February 2017

Abstracts

Journal of Clinical Psychopharmacology

https://doi.org/10.1097/jcp.0000000000000623

The Impact of Atypical Antipsychotic Medications on the Use of Health Care by Patients with Schizophrenia | January 2008

Articles

Value in Health

https://www.sciencedirect.com/science/article/pii/S1098301510604949

The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review | March 2014

Articles

CNS Drugs

https://link.springer.com/article/10.1007/s40263-014-0157-3

Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression | January 2020

Articles

Drug, Healthcare and Patient Safety

https://www.dovepress.com/use-of-atypical-antipsychotics-in-long-term-care-residents-with-parkin-peer-reviewed-article-DHPS

Simultaneous Comparison of Efficacy and Tolerability of Second-Generation Antipsychotics in Schizophrenia: Mixed-Treatment Comparison Analysis Based on Head-to-Head Trial Data | January 2015

Articles

Psychiatry Investigation

https://doi.org/10.4306/pi.2015.12.1.46

Measuring Adherence to Medication in Schizophrenia: The Relationship between Attitudes toward Drug Therapy and Plasma Levels of New-Generation Antipsychotics | December 2014

Articles

International Journal of Neuropsychopharmacology

https://doi.org/10.1093/ijnp/pyu091

The New Generation of Antipsychotic Drugs: How Atypical Are They? | December 2000

Articles

International Journal of Neuropsychopharmacology

https://doi.org/10.1017/S1461145700002042

Reproductive Safety of Second-Generation Antipsychotics: Current Data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics | October 2015

Articles

American Journal of Psychiatry

https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2015.15040506

Baseline Imbalances and Clinical Outcomes of Atypical Antipsychotics in Dementia: A Meta-Epidemiological Study of Randomized Trials | December 2018

Articles

International Journal of Methods in Psychiatric Research

https://onlinelibrary.wiley.com/doi/full/10.1002/mpr.1757

Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis | May 2015

Articles

International Journal of Neuropsychopharmacology

http://dx.doi.org/10.1093/ijnp/pyv060

The Impact of Atypical Antipsychotic Use on Obstructive Sleep Apnea: A Pilot Study and Literature Review | June 2011

Articles (Manuscripts-Versions)

PubMed Central>Sleep Medicine

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789524/

Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective Study | July 2017

Articles

NCBI>Canadian Journal of Psychiatry

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714117/

Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics | June 2018

Articles

Psychiatry Investigation

http://psychiatryinvestigation.org/journal/view.php?doi=10.30773/pi.2018.01.18.1

Pregnancy and Atypical Antipsychotics | September 2009

Articles

NCBI>Psychiatria Danubina

https://www.ncbi.nlm.nih.gov/pubmed/19794358

Discontinuation of Treatment of Schizophrenic Patients Is Driven by Poor Symptom Response: A Pooled Post-Hoc Analysis of Four Atypical Antipsychotic Drugs | December 2005

Articles

BMC Medicine

http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-3-21

Two Cases of Neuroleptic Malignant Syndrome in Elderly Patients Taking Atypical Antipsychotics | June 2013

Articles

NCBI>Shanghai Archives of Psychiatry

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054545/

Discontinuation and Remission Rates and Social Functioning in Patients with Schizophrenia Receiving Second-Generation Antipsychotics: 52-Week Evaluation of JUMPs, a Randomized, Open-Label Study | October 2021

Articles

Psychiatry and Clinical Neurosciences

https://onlinelibrary.wiley.com/doi/10.1111/pcn.13304

First- v. Second-Generation Antipsychotics and Risk for Diabetes in Schizophrenia: Systematic Review and Meta-Analysis | June 2008

Articles

British Journal of Psychiatry

https://doi.org/10.1192/bjp.bp.107.037184

Depression in Schizophrenia: Comparison of First- and Second-Generation Antipsychotic Drugs | December 2007

Abstracts

Schizophrenia Research

http://dx.doi.org/10.1016/j.schres.2007.10.020

Atypical Antipsychotic Prescribing Patterns amongst Child and Adolescent Mental Health Services Clinicians in a Defined National Health Service Trust | March 2016

Articles

Translational Developmental Psychiatry

https://www.tandfonline.com/doi/full/10.3402/tdp.v4.28537

Efficacy of Second-Generation Antipsychotics in Patients at Ultra-High Risk and Those with First- Episode or Multi-Episode Schizophrenia | June 2013

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/efficacy-of-second-generation-antipsychotics-in-patients-at-ultra-high-peer-reviewed-article-NDT

Comparative Effectiveness of Second Generation Long-Acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary | June 2019

Articles

PLOS ONE

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218071

Treatment of Chronic Insomnia with Atypical Antipsychotics: Results from a Follow-Up Study | January 2021

Articles

NCBI>Sleep Science

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157779/

Focus on Lower Risk of Tardive Dyskinesia with Atypical Antipsychotics | January 2006

Articles

CLOCKSS Stanford University-Annals of Clinical Psychiatry

http://www.crossref.org/iPage?doi=10.1080/10401230500464737

Racial Disparities in the Use of Second-Generation Antipsychotics for the Treatment of Schizophrenia | January 2006

Articles

Psychiatric Services

https://ps.psychiatryonline.org/doi/full/10.1176/appi.ps.57.1.133

Atypical Antipsychotics for Acute Manic and Mixed Episodes in Children and Adolescents with Bipolar Disorder: A Review of Efficacy and Tolerability | March 2010

Articles (Manuscripts-Versions)

PubMed Central>Drugs

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882025/

Preliminary Efficacy and Tolerability Profiles of First versus Second-Generation Long-Acting Injectable Antipsychotics in Schizophrenia: A Systematic Review and Meta-Analysis | July 2020

Abstracts

Journal of Psychiatric Research

https://www.sciencedirect.com/science/article/abs/pii/S0022395620308451

Association between Prescription of Conventional or Atypical Antipsychotic Drugs and Mortality in Older Persons with Alzheimer’s Disease | April 2011

Articles

Dementia and Geriatric Cognitive Disorders

https://www.karger.com/Article/FullText/326213

Child and Adolescent Psychiatrists’ Attitudes and Practices Prescribing Second Generation Antipsychotics | March 2014

Articles (Manuscripts-Versions)

George Washington University>Journal of Child and Adolescent Pharmacology

http://hsrc.himmelfarb.gwu.edu/smhs_psych_facpubs/165/

Persistence of Metabolic Monitoring for Psychiatry Inpatients Treated with Second-Generation Antipsychotics Utilizing a Computer-Based Intervention | February 2016

Articles (Manuscripts-Versions)

University of Michigan>Journal of Clinical Pharmacy and Therapeutics

http://hdl.handle.net/2027.42/135222

Second-Generation Antipsychotics for Schizophrenia: A Review of Clinical Pharmacology and Medication-Associated Side Effects | January 2005

Articles

NCBI>Israel Journal of Psychiatry and Related Sciences

https://www.ncbi.nlm.nih.gov/pubmed/16134407

Risk of Hospitalization and Use of First- versus Second-Generation Antipsychotics among Nursing Home Residents | June 2014

Articles

Psychiatric Services

https://ps.psychiatryonline.org/doi/full/10.1176/appi.ps.201300093

Cardiovascular and Cerebrovascular Risk Factors and Events Associated with Second-Generation Antipsychotic Compared to Antidepressant Use in a Non-Elderly Adult Sample: Results from a Claims-Based Inception Cohort Study | February 2015

Articles

World Psychiatry

http://onlinelibrary.wiley.com/doi/10.1002/wps.20187/full

Association of Atypical Antipsychotics and Mortality for Patients Hospitalised with Pneumonia | November 2019

Articles

ERJ Open Research

http://www.mhsynthesis.com/381017/

Metabolic Monitoring and Interventions for Reducing Metabolic Syndrome in Patients Treated with Atypical Antipsychotics: A Review of the Clinical Evidence | July 2011

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

https://www.cadth.ca/metabolic-monitoring-and-interventions-reducing-metabolic-syndrome-patients-treated-atypical